📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
312 analysed today
FollowTelegram
312
Today
149,713
All-time analysed
42,928
Positive
6,662
Negative
91,440
Neutral
8,615
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
147 announcements match the current filters (relevance ≥ 5).
IMP Powers Shareholders Approve Material Related Party Transactions for FY 2026-27
IMP Powers Limited has received shareholder approval through a postal ballot for material Related Party Transactions (RPTs) planned for the 2026-27 financial year. The transactions involve GSEC Limited and Electrify Energy Private Limited. Both ordinary resolutions were passed with a 72.42% majority of the votes polled. The promoter group, holding over 14.47 lakh shares, abstained from voting as they were interested parties in the resolutions.
Key Highlights
Approved material RPTs with GSEC Limited and Electrify Energy Private Limited for the 2026-27 financial year.
Resolutions passed with 5,541 votes (72.42%) in favor and 2,110 votes (27.58%) against.
Total voter participation was low, with only 7,651 votes polled out of a total share base of 86,36,563.
Promoter and Promoter Group (14,47,207 shares) did not participate in the voting process due to conflict of interest.
👀 What to Watch
Investors should monitor the specific financial terms of these related party transactions in future filings to ensure they are conducted at arm's length. The 27.58% dissent among voting minority shareholders suggests a need for transparency regarding these deals.
Saharsh Davuluri Appointed CEO & MD; Neuland Labs to Expand CDMO & Peptide Capacity
Neuland Laboratories has appointed Saharsh Davuluri as CEO & MD to lead its next growth phase, focusing on New Chemical Entities (NCE) and peptides. The company has successfully tripled its contract services revenue over the last three years and currently manages over 20 commercial contracts. Future growth is backed by a four-phase expansion of peptide capacity and a doubling of process development capabilities. The leadership transition sees former CEO Sucheth Davuluri move to Executive Vice Chairman, ensuring management continuity.
Key Highlights
Contract services revenues tripled during the last 3 years, driven by a shift toward NCE-focused CDMO work.
Committed to a four-phase expansion of commercial peptide capacity and doubling of process development capabilities.
Currently operates 3 US FDA-inspected facilities with 1218 KL of total installed capacity.
The company manages over 20 commercial contracts and has filed over 1000 DMFs globally.
Strategic goal set to become one of the world’s top five API-focused CDMOs over the next decade.
👀 What to Watch
Investors should view this as a positive succession that reinforces the company's high-margin CDMO strategy. Monitor the execution of the peptide capacity expansion and the conversion of the NCE pipeline into commercial revenue over the next 12-24 months.
Mukand Ltd Completes Slump Sale of Machinery Business to Subsidiary for ₹45.78 Cr
Mukand Limited has finalized the transfer of its Industrial Machinery Business to its wholly-owned subsidiary, Mukand Heavy Engineering Limited (MHEL). The transaction, valued at ₹45.78 Crores, was executed via a slump sale on a going concern basis as of March 31, 2026. The consideration was settled through the issuance of 26,347 equity shares by MHEL to the parent company. This internal restructuring consolidates the company's crane and process plant equipment manufacturing under a dedicated entity.
Key Highlights
Slump sale of Industrial Machinery Business to 100% subsidiary MHEL completed on March 31, 2026.
Total purchase consideration of ₹45.78 Crores discharged via equity share allotment.
MHEL issued 26,347 fully paid-up equity shares to Mukand Limited as part of the deal.
Transferred business includes designing, manufacturing, and commissioning of EOT Cranes and material handling equipment.
👀 What to Watch
Since this is an internal transfer to a wholly-owned subsidiary, there is no impact on the consolidated financial health of the company. Investors should treat this as a routine corporate restructuring for operational efficiency.
Mukand Ltd Completes Land Sale at Dighe for Rs 555.35 Crore
Mukand Limited has successfully executed conveyance deeds for the sale of land parcels at Dighe, totaling approximately 16.62 acres. The total consideration for this transaction is Rs. 555.35 crore, with the company receiving a final balance of Rs. 445.35 crore after adjusting for previous advances. An additional sale of 3.07 acres at Kalwa for Rs. 110.83 crore is expected to follow once sub-division approvals are obtained. This move is part of the company's strategy to unlock value from its land bank without impacting its industrial operations.
Key Highlights
Total consideration of Rs. 555.35 crore for 16.62 acres of land at Dighe
Received balance payment of Rs. 445.35 crore after adjusting for Rs. 110 crore advance
Future sale of 3.07 acres at Kalwa expected to bring in another Rs. 110.83 crore
Transaction completed with AGP DC Infra Private Limited, a non-related party
Management confirms no impact on the company's manufacturing operations
👀 What to Watch
This significant cash infusion provides Mukand with substantial liquidity to potentially reduce debt or fund capital expenditures. Investors should monitor the company's next quarterly report to see how these proceeds are utilized.
Mukand Ltd Shareholders Approve Re-appointment of Niraj Bajaj and Material RPTs with 99%+ Majority
Mukand Limited shareholders have overwhelmingly approved the re-appointment of Shri Niraj Bajaj as Chairman and Managing Director and Shri Nirav Bajaj as Whole-Time Director via postal ballot. The resolutions included the approval of director remuneration and material related-party transactions (RPT) for FY 2026-27. Specifically, the re-appointment of Niraj Bajaj received 99.99% support, while the RPTs were approved with over 99.45% of the votes. This ensures leadership continuity and provides the necessary approvals for key operational transactions in the upcoming fiscal year.
Key Highlights
Shri Niraj Bajaj re-appointed as Chairman and Managing Director with 99.9985% votes in favor
Shri Nirav Bajaj re-appointed as Whole-Time Director with 99.9984% approval
Material Related Party Transactions for FY 2026-27 approved with 99.4506% majority
Material RPTs for subsidiary Mukand Heavy Engineering Limited secured 99.4506% support
Total valid votes cast for the primary management resolution reached 11,14,94,016 shares
👀 What to Watch
The high level of shareholder support indicates strong confidence in the current management and the company's strategic direction. Investors should continue to monitor the execution of related-party transactions to ensure they remain beneficial to minority shareholders.
Windlas Biotech Shareholders Approve Re-appointment of 3 Directors with 99.99% Majority
Windlas Biotech Limited has announced the results of its postal ballot, where shareholders overwhelmingly approved the re-appointment of three key board members. Mr. Ashok Kumar Windlass was re-appointed as Whole-time Director, while Mr. Vivek Dhariwal and Mr. Gaurav Gulati were re-appointed as Independent Directors. Out of 15,320,885 total valid votes cast, 15,320,883 votes (99.99%) were in favor of the resolutions. This ensures leadership continuity for the company starting May 2026.
Key Highlights
Re-appointment of Ashok Kumar Windlass as Whole-time Director approved with 15,320,883 votes in favor.
Independent Directors Vivek Dhariwal and Gaurav Gulati re-appointed effective May 6, 2026.
High shareholder participation with 72.69% of total outstanding shares polled.
Near-unanimous support from institutional and promoter groups, with only 2 votes cast against the resolutions.
👀 What to Watch
The near-unanimous approval indicates strong shareholder confidence in the current leadership and governance. Investors should view this as a positive sign of stability and continuity in the company's strategic direction.
Raymond Lifestyle Appoints HUL Veteran Kalpana Singh as Chief Marketing Officer
Raymond Lifestyle Limited has appointed Ms. Kalpana Singh as its Chief Marketing Officer, effective March 05, 2026. Ms. Singh is a seasoned professional with 20 years of experience in brand building and consumer insights, including an 18-year tenure at Hindustan Unilever Limited (HUL). Her previous roles include Marketing Director at HUL and regional leadership positions across the Middle East, Turkey, and North Africa. This appointment is expected to bolster the company's strategic marketing and brand positioning efforts in the lifestyle sector.
Key Highlights
Ms. Kalpana Singh appointed as Chief Marketing Officer (CMO) effective March 05, 2026
Brings 20 years of distinguished experience in brand building and category strategy
Spent 18 years at Hindustan Unilever Limited (HUL) in various senior leadership roles
Previously served as Marketing Director at HUL and Business Group Director for international regions
Will report directly to the Chief Executive Officer (CEO) as part of the Senior Management Personnel
👀 What to Watch
Investors should view this as a positive move to strengthen the leadership team with top-tier FMCG talent. Monitor the impact of new marketing initiatives on brand growth and market share over the next few quarters.
IMP Powers Seeks Shareholder Approval for Material Related Party Transactions for FY 2026-27
IMP Powers Limited has initiated a postal ballot process to obtain shareholder approval for material related party transactions (RPTs) planned for the financial year 2026-27. The proposed transactions involve GSEC Limited and Electrify Energy Private Limited, a promoter group entity. Voting is conducted through a remote e-voting facility open from February 27, 2026, to March 28, 2026. The company maintains that these transactions will be conducted in the ordinary course of business and at arm's length.
Key Highlights
Proposed material RPTs with GSEC Limited for the financial year 2026-27.
Proposed material RPTs with Electrify Energy Private Limited (Promoter Company) for FY 2026-27.
Remote e-voting period scheduled from February 27, 2026, to March 28, 2026.
Eligibility for voting determined by the cut-off date of February 20, 2026.
Results of the postal ballot to be declared within two working days of the voting closure.
👀 What to Watch
Investors should examine the specific transaction limits and nature of business with these related parties to ensure no conflict of interest. Monitor the voting outcome to be announced by March 30, 2026.
Mukand Ltd Seeks Approval for Re-appointment of CMD and Material Related Party Transactions
Mukand Limited has issued a postal ballot notice seeking shareholder approval for the re-appointment of Shri Niraj Bajaj as Chairman and Managing Director for a 3-year term starting July 5, 2026. The company is also proposing the re-appointment of Shri Nirav Bajaj as Whole-Time Director for 3 years effective May 16, 2026. Additionally, resolutions are being presented for material related party transactions for FY 2026-27 involving the company and its subsidiary, Mukand Heavy Engineering Limited. The e-voting period for these resolutions runs from February 20 to March 21, 2026.
Key Highlights
Proposed re-appointment of Shri Niraj Bajaj as CMD for 3 years starting July 5, 2026
Proposed re-appointment of Shri Nirav Bajaj as Whole-Time Director for 3 years starting May 16, 2026
Approval sought for material related party transactions for FY 2026-27
Remote e-voting period scheduled from February 20, 2026, to March 21, 2026
Results of the postal ballot to be declared on or before March 24, 2026
👀 What to Watch
Investors should review the proposed remuneration and the nature of the material related party transactions to ensure they align with corporate governance standards. Eligible shareholders should participate in the e-voting process before the March 21 deadline.
NDL Ventures Receives CCI Approval for Merger with Hinduja Leyland Finance
NDL Ventures Limited has received a critical regulatory approval from the Competition Commission of India (CCI) for its proposed merger with Hinduja Leyland Finance Limited. The approval, granted on February 17, 2026, follows the initial board approval of the scheme on November 25, 2025. This merger aims to absorb the finance entity into NDL Ventures, significantly altering the company's business profile. While this is a major milestone, the scheme remains subject to further approvals from SEBI, Stock Exchanges, and the National Company Law Tribunal (NCLT).
Key Highlights
CCI granted approval under Section 31(1) of the Competition Act, 2002, on February 17, 2026.
The merger involves the absorption of Hinduja Leyland Finance Limited into NDL Ventures Limited.
The Board of Directors had previously approved the scheme on November 25, 2025.
The transaction still requires final clearance from SEBI, Stock Exchanges, and the NCLT.
👀 What to Watch
Investors should maintain a positive outlook as a major regulatory hurdle has been cleared for the merger. Monitor the timeline for NCLT approval which will be the final step in the consolidation process.
Windlas Biotech Seeks Approval for Director Re-appointments and ₹1.56 Cr Annual Remuneration
Windlas Biotech has initiated a postal ballot to seek shareholder approval for the re-appointment of Mr. Ashok Kumar Windlass as Whole-time Director for a five-year term starting May 3, 2026. The proposal includes a fixed annual remuneration of ₹1.56 crore and requires a special resolution as he is over 75 years of age. Additionally, the company is seeking a second five-year term for Independent Directors Mr. Vivek Dhariwal and Mr. Gaurav Gulati. Shareholders can participate in remote e-voting from February 18 to March 19, 2026.
Key Highlights
Proposed re-appointment of Mr. Ashok Kumar Windlass as WTD for 5 years with ₹1.56 crore annual salary.
Special resolution required for Mr. Windlass to continue in office beyond the age of 75 years.
Re-appointment of two Independent Directors, Vivek Dhariwal and Gaurav Gulati, for second 5-year terms.
Remote e-voting period set for February 18, 2026, to March 19, 2026, with a cut-off date of February 13.
Aggregate remuneration of promoter executive directors may exceed SEBI Regulation 17(6)(e) limits but will remain within Section 197 ceilings.
👀 What to Watch
Investors should monitor the voting results to ensure leadership continuity and evaluate if the proposed remuneration aligns with the company's performance. No immediate portfolio changes are necessary based on this routine governance update.
IMP Powers Reports Q3 Net Loss of ₹2.17 Crore; Auditors Issue Qualified Opinion
IMP Powers Limited reported a standalone net loss of ₹217.10 lakhs for the quarter ended December 31, 2025, a significant increase from the ₹108.86 lakhs loss in the prior year's quarter. Revenue from operations remains extremely low at just ₹12.76 lakhs for the quarter, though up slightly from ₹8.14 lakhs year-on-year. The statutory auditors have issued a qualified opinion, highlighting concerns over unconfirmed trade receivables, lack of impairment testing on assets, and improper inventory valuation. For the nine-month period, the company's total loss has reached ₹630.78 lakhs, indicating deep financial distress.
Key Highlights
Net loss for Q3 FY26 widened to ₹217.10 lakhs from ₹108.86 lakhs in Q3 FY25.
Revenue from operations remains negligible at ₹12.76 lakhs for the quarter.
Auditors issued a qualified opinion citing failure to perform impairment testing despite significant operational reductions.
Inventory is currently understated as the company failed to include direct labor and manufacturing overheads in its valuation.
Trade receivables, other financial assets, and bank balances are subject to pending confirmations and reconciliations.
👀 What to Watch
Investors should exercise extreme caution as the company faces severe financial instability, negligible revenues, and multiple auditor qualifications regarding its financial reporting. The lack of impairment testing and inventory discrepancies suggest significant risks to the carrying value of assets.
IMP Powers Reports Q3 Net Loss of ₹217 Lakhs; Auditor Issues Qualified Opinion
IMP Powers Limited reported a net loss of ₹217.10 Lakhs for the quarter ended December 31, 2025, widening from a loss of ₹108.64 Lakhs in the previous year's corresponding quarter. Total income for the quarter stood at ₹163.50 Lakhs, a decline from ₹181.60 Lakhs year-on-year. The statutory auditors have issued a qualified opinion, highlighting that the company failed to perform impairment testing despite significant operational reductions and ongoing losses. Furthermore, the company resumed manufacturing but failed to include direct labor and overheads in inventory valuation, leading to understated inventory figures.
Key Highlights
Net loss widened to ₹217.10 Lakhs in Q3 FY26 compared to ₹108.64 Lakhs in Q3 FY25.
Total income for the quarter decreased to ₹163.50 Lakhs from ₹181.60 Lakhs year-on-year.
Auditors issued a qualified opinion citing lack of impairment testing on assets despite indicators of potential impairment.
Inventory valuation for the quarter excluded direct labor and manufacturing overheads, resulting in understated inventory and potentially overstated expenses.
Trade receivables, other financial assets, and bank balances are subject to pending confirmations and reconciliations.
👀 What to Watch
Investors should exercise extreme caution as the company continues to report losses and faces significant auditor qualifications regarding asset valuation and financial reconciliations. The lack of impairment testing and inventory valuation issues suggest that the reported financial position may not accurately reflect the underlying asset quality.
Neuland Labs Q3FY26 Revenue Up 11.4% to ₹447.8 Cr; EBITDA Margin Dips to 19%
Neuland Laboratories reported an 11.4% YoY increase in total income to INR 447.8 crores for Q3FY26, with the CMS (CDMO) segment contributing over 50% of revenue. EBITDA margins compressed to 19% from previous highs, primarily due to a shift in product mix and a one-time INR 10 crore impact from labor codes. Despite a significant 9-month capex of INR 254 crores, the company maintains a strong net cash position of INR 202.6 crores. Management noted that the absence of a specific high-margin CMS product shipment and delays in Paliperidone contributed to the quarterly margin dip.
Key Highlights
Total income grew 11.4% YoY to INR 447.8 crores, driven by commercial CMS projects.
EBITDA margin stood at 19%; adjusted for a INR 10 crore labor code impact, the margin would be 21%.
9-month gross margin remains healthy at 56% compared to 55% in the previous year.
Significant 9-month capex of INR 254 crores funded largely through internal accruals and customer advances.
Working capital cycle stretched to 145 days due to higher inventories and uneven delivery flows.
👀 What to Watch
Investors should look past the quarterly margin volatility and focus on the successful ramp-up of expanded CMS capacity in Unit 3. The company's transition toward complex molecules and peptides remains the primary long-term value driver.
Mukand Ltd Q3 PAT at ₹17.21 Cr; Niraj Bajaj Re-appointed as CMD for 3 Years
Mukand Limited reported a standalone Profit After Tax (PAT) of ₹17.21 crore for the quarter ended December 31, 2025, a slight increase from ₹16.31 crore in the previous year. Total income for the quarter rose to ₹1,309.67 crore compared to ₹1,225.00 crore year-on-year. The board approved the re-appointment of Niraj Bajaj as Chairman and Managing Director and Nirav Bajaj as Whole-Time Director for three-year terms starting in 2026. Additionally, the company is progressing on a significant ₹673 crore land sale in Thane and a restructuring of its Industrial Machinery Division.
Key Highlights
Standalone Total Income for Q3 FY26 rose to ₹1,309.67 crore from ₹1,225.00 crore YoY.
Net Profit for the quarter stood at ₹17.21 crore, showing marginal growth from ₹16.31 crore in Q3 FY25.
Company executed an agreement to sell land parcels in Thane for ₹673 crore, with ₹110 crore advance received.
Niraj Bajaj re-appointed as CMD for 3 years effective July 5, 2026, ensuring leadership continuity.
Industrial Machinery Division is being transferred to a wholly-owned subsidiary via slump sale for better operational focus.
👀 What to Watch
Investors should track the progress of the ₹673 crore land monetization as it will significantly improve the company's liquidity and debt profile. The leadership continuity is a positive sign, though the marginal growth in bottom-line profits warrants a cautious watch on operating margins.
Mukand Ltd Q3 Net Profit Rises to ₹17.21 Cr; Re-appoints Niraj Bajaj as CMD
Mukand Limited reported a consolidated net profit of ₹17.21 crore for the quarter ended December 31, 2025, a slight increase from ₹16.31 crore in the year-ago period. Revenue from operations grew to ₹1,300.18 crore, up from ₹1,222.67 crore year-on-year. A significant highlight is the ongoing sale of 17.77 acres of land in Thane for approximately ₹673 crore, for which the company has already received a ₹110 crore advance. The board also ensured leadership continuity by re-appointing Niraj Bajaj as Chairman and Managing Director for a three-year term starting July 2026.
Key Highlights
Revenue from operations increased to ₹1,300.18 crore in Q3 FY26 from ₹1,222.67 crore in Q3 FY25.
Net profit for the quarter stood at ₹17.21 crore, showing steady growth from ₹15.90 crore in the previous quarter.
Agreement executed for land sale worth ₹673 crore in Thane, with ₹110 crore advance already received.
Niraj Bajaj re-appointed as CMD and Nirav Bajaj as Whole-Time Director for 3-year terms starting in 2026.
Slump sale of the Industrial Machinery Division to subsidiary MHEL is expected to be completed shortly.
👀 What to Watch
Investors should focus on the successful closure of the ₹673 crore land sale as it will significantly improve the company's liquidity and debt profile. The steady earnings and management continuity suggest a stable outlook, making it a 'Watch' for further deleveraging milestones.
Nandan Denim Q3 FY26 Net Profit Drops 55% YoY to ₹2.97 Crore; Revenue Slumps 46%
Nandan Denim Limited reported a significant downturn in its financial performance for the quarter ended December 31, 2025. Revenue from operations fell sharply by 46% year-on-year to ₹499.53 crore, while net profit declined by 55% to ₹2.97 crore compared to the same quarter last year. Sequentially, the results were even weaker, with net profit dropping from ₹9.45 crore in the preceding quarter. The company is also currently addressing regulatory penalties from BSE and NSE regarding non-compliance with board composition norms.
Key Highlights
Revenue from operations decreased 46% YoY to ₹49,952.72 lakhs in Q3 FY26.
Net profit for the quarter fell 55% YoY to ₹297.29 lakhs from ₹658.00 lakhs.
Total expenses for the quarter stood at ₹49,687.45 lakhs, significantly lower than ₹91,937.22 lakhs YoY.
The company has applied for a waiver of penalties levied by BSE and NSE for non-compliance with Regulation 17(1A).
Nine-month net profit remains slightly higher at ₹2,361.89 lakhs compared to ₹2,284.90 lakhs in the previous year.
👀 What to Watch
Investors should exercise caution as the sharp decline in quarterly revenue and profitability suggests operational headwinds. Monitor the stock for management's explanation regarding the revenue contraction and the resolution of the regulatory penalty issue.
Mukand Ltd Q3 PAT Rises to ₹17.21 Cr; Board Approves ₹673 Cr Land Sale and CMD Re-appointment
Mukand Limited reported a steady performance for Q3 FY26 with a standalone net profit of ₹17.21 crore, up from ₹16.31 crore in the same quarter last year. Revenue from operations saw a modest growth of 6.3% YoY, reaching ₹1,300.18 crore. A significant highlight is the ongoing sale of 17.77 acres of land in Thane for ₹673 crore, which is expected to provide a substantial liquidity boost. The board also ensured leadership continuity by re-appointing Niraj Bajaj as Chairman and Managing Director for a three-year term starting July 2026.
Key Highlights
Standalone Revenue from Operations grew to ₹1,300.18 crore in Q3 FY26 compared to ₹1,222.67 crore in Q3 FY25.
Net Profit for the quarter stood at ₹17.21 crore, including a loss of ₹4.14 crore from discontinuing operations.
Executed agreement for sale of land parcels in Thane for approximately ₹673 crore, with ₹110 crore advance already received.
Re-appointed Niraj Bajaj as CMD and Nirav Bajaj as Whole-Time Director for 3-year terms starting in 2026.
Proceeding with the slump sale of the Industrial Machinery Division to a wholly-owned subsidiary to streamline business structure.
👀 What to Watch
Investors should view the ₹673 crore land sale as a major positive catalyst for debt reduction and balance sheet strengthening. While operational growth is modest, leadership stability and asset monetization plans make this a stock to watch for value unlocking.
Mukand Ltd Q3 PAT at ₹17.21 Cr; Land Sale for ₹673 Cr and CMD Re-appointment Approved
Mukand Limited reported a Profit After Tax (PAT) of ₹17.21 crore for Q3 FY26, a slight increase from ₹16.31 crore in the previous year's corresponding quarter. Revenue from operations rose to ₹1,300.18 crore, reflecting stable demand. A major highlight is the ongoing sale of land parcels for ₹673 crore, which is expected to provide a substantial liquidity boost upon completion. The board also ensured management continuity by re-appointing Niraj Bajaj as Chairman and Managing Director for another three years.
Key Highlights
Q3 FY26 Revenue from operations increased to ₹1,300.18 crore from ₹1,222.67 crore YoY.
Net Profit for the quarter reached ₹17.21 crore, up from ₹16.31 crore in Q3 FY25.
Progressing on a ₹673 crore land sale in Thane; ₹110 crore advance already received.
Industrial Machinery Division being transferred to a subsidiary via slump sale for better focus.
Niraj Bajaj re-appointed as CMD for a 3-year term effective July 2026.
👀 What to Watch
Investors should monitor the realization of the remaining ₹563 crore from the land sale as it could significantly strengthen the balance sheet. The steady operational performance and leadership continuity provide a positive outlook for long-term holders.
Nandan Denim Q3 FY26 Net Profit Falls 55% YoY to ₹2.97 Cr; Revenue Down 46%
Nandan Denim reported a sharp decline in its financial performance for the quarter ended December 31, 2025, with revenue from operations dropping 46% YoY to ₹499.53 crore. Net profit for the quarter fell to ₹2.97 crore from ₹6.58 crore in the previous year's corresponding quarter. On a sequential basis, revenue also saw a significant contraction from ₹784.69 crore in Q2 FY26. Furthermore, the company is currently contesting penalties levied by BSE and NSE regarding non-compliance with SEBI Regulation 17(1A).
Key Highlights
Revenue from operations declined 46% YoY to ₹499.53 crore from ₹926.15 crore.
Net Profit decreased by 54.8% YoY to ₹2.97 crore compared to ₹6.58 crore in Q3 FY25.
Total expenses were significantly lower at ₹496.87 crore versus ₹919.37 crore YoY, driven by reduced material costs.
Earnings Per Share (EPS) for the quarter stood at ₹0.02, down from ₹0.05 YoY.
The company has applied for a waiver of penalties from stock exchanges regarding Board composition non-compliance.
👀 What to Watch
Investors should exercise caution as the company shows a significant contraction in scale and profitability. Monitor the resolution of the regulatory penalty and look for signs of margin stabilization in upcoming quarters.
